FXAIX
Price
$210.71
Change
-$0.82 (-0.39%)
Updated
Dec 17 closing price
TFFCX
Price
$66.96
Change
-$0.20 (-0.30%)
Updated
Dec 17 closing price
Ad is loading...

FXAIX vs TFFCX

Header iconFXAIX vs TFFCX Comparison
Open Charts FXAIX vs TFFCXBanner chart's image
Fidelity 500 Index
Price$210.71
Change-$0.82 (-0.39%)
VolumeN/A
CapitalizationN/A
Touchstone Focused C
Price$66.96
Change-$0.20 (-0.30%)
VolumeN/A
CapitalizationN/A
FXAIX vs TFFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. TFFCX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and TFFCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 632B vs. TFFCX (1.35B). FXAIX pays higher dividends than TFFCX: FXAIX (1.31) vs TFFCX (0.00). FXAIX was incepted earlier than TFFCX: FXAIX (14 years) vs TFFCX (13 years). TFFCX is a more actively managed with annual turnover of: 5.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than TFFCX: FXAIX (0) vs TFFCX (2500). FXAIX annual gain was more profitable for investors over the last year : 29.40 vs. TFFCX (20.84). FXAIX return over 5 years is better than : 104.23 vs. TFFCX (59.69).
FXAIXTFFCXFXAIX / TFFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD28.55020.280141%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets632B1.35B46,815%
Annual Yield % from dividends1.310.00-
Returns for 1 year29.4020.84141%
Returns for 3 years37.1418.22204%
Returns for 5 years104.2359.69175%
Returns for 10 years217.9189.75243%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CANG6.911.42
+25.87%
Cango
CYRX8.140.42
+5.44%
CryoPort
CBOE198.082.43
+1.24%
Cboe Global Markets
ALE64.680.01
+0.02%
ALLETE
PAVM0.68-0.04
-5.61%
PAVmed